Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company NeuroDerm Ltd.
DescriptionHigh-dose formulation of levodopa and carbidopa delivered via a small belt pump
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today